Zobrazeno 1 - 10
of 282
pro vyhledávání: '"Ambros J Beer"'
Autor:
Elham Yousefzadeh-Nowshahr, Gordon Winter, Peter Bohn, Katharina Kneer, Christine A F von Arnim, Markus Otto, Christoph Solbach, Sarah Anderl-Straub, Dörte Polivka, Patrick Fissler, Joachim Strobel, Peter Kletting, Matthias W Riepe, Makoto Higuchi, Gerhard Glatting, Albert Ludolph, Ambros J Beer, Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0266906 (2022)
PurposeThe recent developments of tau-positron emission tomography (tau-PET) enable in vivo assessment of neuropathological tau aggregates. Among the tau-specific tracers, the application of 11C-pyridinyl-butadienyl-benzothiazole 3 (11C-PBB3) in PET
Externí odkaz:
https://doaj.org/article/5e8b71795e9c4e0099d9d89336fde267
Autor:
Kathrin Philipp‐Abbrederis, Ken Herrmann, Stefan Knop, Margret Schottelius, Matthias Eiber, Katharina Lückerath, Elke Pietschmann, Stefan Habringer, Carlos Gerngroß, Katharina Franke, Martina Rudelius, Andreas Schirbel, Constantin Lapa, Kristina Schwamborn, Sabine Steidle, Elena Hartmann, Andreas Rosenwald, Saskia Kropf, Ambros J Beer, Christian Peschel, Hermann Einsele, Andreas K Buck, Markus Schwaiger, Katharina Götze, Hans‐Jürgen Wester, Ulrich Keller
Publikováno v:
EMBO Molecular Medicine, Vol 7, Iss 4, Pp 477-487 (2015)
Abstract CXCR4 is a G‐protein‐coupled receptor that mediates recruitment of blood cells toward its ligand SDF‐1. In cancer, high CXCR4 expression is frequently associated with tumor dissemination and poor prognosis. We evaluated the novel CXCR4
Externí odkaz:
https://doaj.org/article/b94bc3fe20304d139146df2d3df76b5d
Autor:
Peter Kletting, Christiane Schuchardt, Harshad R Kulkarni, Mostafa Shahinfar, Aviral Singh, Gerhard Glatting, Richard P Baum, Ambros J Beer
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162303 (2016)
In molecular radiotherapy with 177Lu-labeled prostate specific membrane antigen (PSMA) peptides, kidney and/or salivary glands doses limit the activity which can be administered. The aim of this work was to investigate the effect of the ligand amount
Externí odkaz:
https://doaj.org/article/84cf762f2a6e41a3bd5c9d80d2f21c84
Autor:
Stefanie M F Seiler, Christine Baumgartner, Johannes Hirschberger, Ambros J Beer, Andreas Brühschwein, Nina Kreutzmann, Silja Laberke, Melanie C Wergin, Andrea Meyer-Lindenberg, Johanna Brandl, Anne-Kathrin von Thaden, Eliane Farrell, Markus Schwaiger
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0127800 (2015)
Introduction2-Deoxy-2-[18F]fluoro-D-glucose PET/CT is a well-established imaging method for staging, restaging and therapy-control in human medicine. In veterinary medicine, this imaging method could prove to be an attractive and innovative alternati
Externí odkaz:
https://doaj.org/article/116c716dc68c40fb92dcd5dbefccf492
Autor:
Stephan Metz, Carl Ganter, Sylvie Lorenzen, Sandra van Marwick, Konstantin Holzapfel, Ken Herrmann, Ernst J Rummeny, Hans-Jürgen Wester, Markus Schwaiger, Stephan G Nekolla, Ambros J Beer
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132386 (2015)
Diffusion-weighted magnetic resonance imaging (DW-MRI) and imaging of glucose metabolism by positron emission tomography (FDG-PET) provide quantitative information on tissue characteristics. Combining the two methods might provide novel insights into
Externí odkaz:
https://doaj.org/article/c90f83e340b8415badfb8cf046d8e8e6
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127934 (2015)
Radioimmunotherapy (RIT) with 90Y-labeled anti-CD66 antibody is used to selectively irradiate the red marrow (RM) before blood stem cell transplantation of acute leukemia patients. To calculate the activity to administer, time-integrated activity coe
Externí odkaz:
https://doaj.org/article/976796eff93b4754b6c2a42227773241
Autor:
Reinhard Meier, Rickmer Braren, Yvonne Kosanke, Johanna Bussemer, Frauke Neff, Moritz Wildgruber, Sarah Schwarzenböck, Annette Frank, Bernhard Haller, Andreas M Hohlbaum, Markus Schwaiger, Hendrik Gille, Ernst J Rummeny, Ambros J Beer
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e94972 (2014)
Anticalins are a novel class of targeted protein therapeutics. The PEGylated Anticalin Angiocal (PRS-050-PEG40) is directed against VEGF-A. The purpose of our study was to compare the performance of diffusion weighted imaging (DWI), dynamic contrast
Externí odkaz:
https://doaj.org/article/5fa91d33401c4942959a4d6698927875
Autor:
Roland Haubner, Wolfgang A Weber, Ambros J Beer, Eugenija Vabuliene, Daniel Reim, Mario Sarbia, Karl-Friedrich Becker, Michael Goebel, Rüdiger Hein, Hans-Jürgen Wester, Horst Kessler, Markus Schwaiger
Publikováno v:
PLoS Medicine, Vol 2, Iss 3, p e70 (2005)
BACKGROUND: The integrin alphavbeta3 plays an important role in angiogenesis and tumor cell metastasis, and is currently being evaluated as a target for new therapeutic approaches. Several techniques are being studied to enable noninvasive determinat
Externí odkaz:
https://doaj.org/article/bbff4d19965a40a4bcd8f3f71b29aa47
Autor:
Jürgen C. Becker, Ambros J. Beer, Viola K. DeTemple, Thomas Eigentler, Michael Flaig, Thilo Gambichler, Stephan Grabbe, Ulrike Höller, Bernhard Klumpp, Stephan Lang, Claudia Pföhler, Christian Posch, Vikas Prasad, Peter Schlattmann, Sylke Schneider‐Burrus, Jan Ter‐Nedden, Patrick Terheyden, Kai Thoms, Dirk Vordermark, Selma Ugurel
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 21:305-320
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bacbded47862c29f4eaaa9887a71bd85
https://doi.org/10.1111/ddg.14930
https://doi.org/10.1111/ddg.14930
Autor:
Albrecht Stenzinger, Robert Thimme, Ambros J. Beer, Oliver Kohlbacher, Anna Wedell, Michael Bitzer, Mikaela Friedman, Mia Wadelius, Thomas Seufferlein, Per Sikora, Peter Kuhn, Thoas Fioretos, Hans Ehrencrona, Stefan Fröhling, Justus Duyster, Anna Lindstrand, Lars Engstrand, Verena I. Gaidzik, Johan Botling, Melanie Boerries, Lucia Cavelier, Anna Lena Illert, Martin Hallbeck, Michael Akhras, Gisela Helenius, Christopher Schroeder, Jan Budczies, Anders Edsjö, Valtteri Wirta, Carolin Ploeger, Silke Lassmann, Erik Melén, Lars Palmqvist, Maréne Landström, Peter Schirmacher, Lovisa Lovmar, Peter Horak, David Gisselsson, Nisar P. Malek, Lars-Åke Levin, Richard Rosenquist, Konstantin Nikolaou
Publikováno v:
Seminars in Cancer Biology. 84:242-254
Over the last decades, rapid technological and scientific advances have led to a merge of molecular sciences and clinical medicine, resulting in a better understanding of disease mechanisms and the development of novel therapies that exploit specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c8cb8495d982ddf55bd8513512b3b78
https://doi.org/10.1016/j.semcancer.2021.05.026
https://doi.org/10.1016/j.semcancer.2021.05.026